| 08/18/2026 8:00 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 3:29 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/17/2026 3:40 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/13/2026 2:45 PM | MORGAN STANLEY (895421) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 08/06/2026 6:28 AM | Roivant Sciences (1635088) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/06/2026 6:13 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/29/2026 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 8:00 PM | Oren Ilan (1643073) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 8:00 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 8:00 PM | MOMTAZEE JAMES C (1209181) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 6:00 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ROIV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Roivant Sciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/02/2026 6:01 PM | Roivant Sciences (1635088) Issuer Torti Frank (1647805) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 6:03 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 6:06 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 5:34 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 7:38 PM | MANCHESTER KEITH S (1244828) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 7:30 PM | Gold Daniel Allen (1832142) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 6:59 PM | QVT Financial LP (1290162) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 3:36 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/29/2026 5:23 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/29/2026 3:40 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/26/2026 5:13 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 3:33 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/24/2026 3:01 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/23/2026 8:16 PM | Humes Jennifer (2058012) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 8:17 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 5:25 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 5:22 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/20/2026 3:40 PM | Roivant Sciences (1635088) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 05/20/2026 6:14 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 6:17 AM | Roivant Sciences (1635088) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 05/12/2026 12:19 PM | MORGAN STANLEY (895421) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 05/06/2026 8:07 PM | Ramaswamy Vivek (1635075) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 04/22/2026 5:26 PM | Humes Jennifer (2058012) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 5:26 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 5:27 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 8:00 PM | Oren Ilan (1643073) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 5:32 PM | MOMTAZEE JAMES C (1209181) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 5:34 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 5:27 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 3:17 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Buffett's Final Warning: "The Dollar Is Going to Hell" (Ad) The US just hit $39 trillion in debt. Interest alone is now over $1 trillion a year, more than the entire defense budget. There's no way to tax our way out. No way to cut our way out. The government has exactly one move left:
Pump trillions into AI to outgrow the debt. And the asset class profiting from these trillions in spending. BlackRock is buying. Goldman Sachs is buying. Gartner is calling it the next decade defining boom.
The last time a similar setup formed, early investors saw gains of up to 12,480%. I've put together a workshop breaking this down in detail. I'll name the asset class and show you exactly how to profit from this $39 trillion debt crisis. Click here to register for the free workshop → |
| 04/16/2026 4:24 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Subject | Form 144/A | |
| 04/16/2026 3:33 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/10/2026 5:00 PM | Humes Jennifer (2058012) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/08/2026 3:07 PM | Humes Jennifer (2058012) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/02/2026 6:14 PM | Roivant Sciences (1635088) Issuer Torti Frank (1647805) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 6:00 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/01/2026 6:19 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 6:20 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 8:01 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 3:14 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/24/2026 6:07 PM | Humes Jennifer (2058012) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 6:08 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 7:44 AM | Roivant Sciences (1635088) Filer | Form 8-K/A | |
| 03/19/2026 5:36 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 5:23 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 3:17 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/16/2026 3:04 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/06/2026 9:05 AM | FMR LLC (315066) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 03/03/2026 6:13 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/24/2026 5:43 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 5:43 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 7:40 PM | Roivant Sciences (1635088) Issuer Torti Frank (1647805) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 3:24 PM | Roivant Sciences (1635088) Subject Torti Frank (1647805) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/18/2026 4:57 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 8:00 PM | Gold Daniel Allen (1832142) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 8:02 PM | MANCHESTER KEITH S (1244828) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 7:45 PM | QVT Financial LP (1290162) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 2:32 PM | Ramaswamy Vivek (1635075) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 02/11/2026 4:53 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 10:50 AM | MORGAN STANLEY (895421) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 02/06/2026 6:31 AM | Roivant Sciences (1635088) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 02/06/2026 6:12 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/05/2026 12:36 PM | FMR LLC (315066) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 01/22/2026 8:00 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:00 PM | Oren Ilan (1643073) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 8:00 PM | MOMTAZEE JAMES C (1209181) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/14/2026 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 3:04 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/31/2025 8:00 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/31/2025 3:30 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/29/2025 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 8:00 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 8:00 PM | Roivant Sciences (1635088) Issuer Torti Frank (1647805) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 3:31 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/29/2025 8:36 AM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/29/2025 8:05 AM | Roivant Sciences (1635088) Subject Torti Frank (1647805) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/23/2025 8:00 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 3:19 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/23/2025 3:04 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/19/2025 8:04 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself |
| 12/18/2025 6:52 PM | MANCHESTER KEITH S (1244828) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 6:54 PM | Gold Daniel Allen (1832142) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 6:41 PM | QVT Financial LP (1290162) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 8:00 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 4:09 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 8:34 PM | Ramaswamy Vivek (1635075) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 4:13 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Subject | Form 144/A | |
| 12/15/2025 3:36 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/12/2025 4:20 PM | Immunovant, Inc. (1764013) Subject Roivant Sciences (1635088) Filed by | Form SCHEDULE 13D/A | |